Oxysophocarpine attenuates inflammatory osteolysis by modulating the NF-κb pathway and the reactive oxygen species-related Nrf2 signaling pathway

Xiaofeng Shi,Tian Gao,Chaohong Yu,Shaotian Fu,Tingxian Guo,Wei Xu,Xiaojun Li,Yitian Wang,Jingwei Zhang,Xinlin Jia,Yuanqing Mao
DOI: https://doi.org/10.1007/s10787-024-01552-6
2024-08-19
Inflammopharmacology
Abstract:Inflammatory diseases often result in bone loss due to persistent inflammation, which activates osteoclasts and increases bone resorption. Oxysophocarpine (OSC), a bioalkaloid extracted from the roots of Sophora japonica and other leguminous plants, has neuroprotective and anti-tumor properties. However, it is still uncertain whether OSC can effectively inhibit the differentiation of osteoclasts and bone resorption. Therefore, this study explored the potential role of OSC in osteoclast formation and inflammatory osteolysis and its underlying mechanisms.
immunology,toxicology
What problem does this paper attempt to address?